Inventor · disambiguated record
Andrea Rizzi
Also filed as: RIZZI ANDREA
19 granted patents·12 pending applications·64 citations·filing 2004–2023
92Inventor score
Top patents by PatentIndex Score
31 records- 0187US9199980B2CompoundsCHIESI FARMA SPA·Filed 2013·Granted Dec 1, 2015·5 cites·13 claims
- 0287US8022250B21-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseasesCHIESI FARMA SPA·Filed 2009·Granted Sep 20, 2011·10 cites·6 claims
- 0387US7820698B2Phosphodiesterase-4 inhibitors belonging to the tertiary amine classCHIESI FARMA SPA·Filed 2009·Granted Oct 26, 2010·16 cites·24 claims
- 0479US7662995B21-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseasesCHIESI FARMA SPA·Filed 2004·Granted Feb 16, 2010·12 cites·26 claims
- 0577US10004728B2Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2017·Granted Jun 26, 2018·2 cites·12 claims
- 0676US9579314B2Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2016·Granted Feb 28, 2017·2 cites·14 claims
- 0775US9662323B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2016·Granted May 30, 2017·2 cites·16 claims
- 0874US8877774B2Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activityRANCATI FABIO·Filed 2012·Granted Nov 4, 2014·4 cites·21 claims
- 0973US9012644B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityRANCATI FABIO·Filed 2012·Granted Apr 21, 2015·3 cites·19 claims
- 1072US8314268B21-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseasesRAVEGLIA LUCA·Filed 2011·Granted Nov 20, 2012·3 cites·18 claims
- 1171US7838534B2Quinuclidine derivatives as M3 antagonistsCHIESI FARMA SPA·Filed 2007·Granted Nov 23, 2010·2 cites·8 claims
- 1269US7531692B2Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseasesCHIESI FARMA SPA·Filed 2005·Granted May 12, 2009·1 cites·21 claims
- 1364US8481517B2Pyrrolidine compounds,pharmaceutical compositions containing the same, devices containing the same, and methods of treating asthma or chronic obstructive pulmonary disease by administering the sameGHIDINI ELEONORA·Filed 2011·Granted Jul 9, 2013·2 cites·15 claims
- 1461US2025250232A1Azetidine derivatives and use thereof as dipeptidyl peptidase 1 inhibitorsCHIESI FARM SPA·Filed 2023·Application pending·0 cites
- 1559US9845337B2Isoxazolidine derivativesCHIESI FARM SPA·Filed 2014·Granted Dec 19, 2017·0 cites·12 claims
- 1659US2024425482A1Pyrrolidine derivatives as ddrs inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 1755US2024391936A1Tetrahydrothieno pyridine derivatives as ddrs inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 1855US2024279240A1Heterocyclic derivatives as janus kinase inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 1955US2024166651A1Heterocyclic derivatives as janus kinase inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 2055US2024199635A1Tetrahydrothieno pyridine derivatives as ddrs inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 2155US2024217967A1Indoline derivatives as ddrs inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 2254US12454530B2Amido cyclohexane acid derivatives as LPA receptor inhibitorsCHIESI FARM SPA·Filed 2021·Granted Oct 28, 2025·0 cites·11 claims
- 2354US10280193B2Isoxazolidine derivativesCHIESI FARM SPA·Filed 2017·Granted May 7, 2019·0 cites·10 claims
- 2454US2024209001A1Heterocyclic derivatives as janus kinase inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 2554US2024190847A1Indoline derivatives as ddr1 and ddr2 inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 2653US2023227447A1Benzylamine derivatives as ddrs inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 2749US2012234316A1Isoxazolidine derivativesGHIDINI ELEONORA·Filed 2012·Application pending·0 cites
- 2846US10087176B23,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)--2-carbonyloxy)ethyl)pyridine derivatives as PDE-4 inhibitorsCHIESI FARM SPA·Filed 2014·Granted Oct 2, 2018·0 cites·6 claims
- 2940US10196386B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2017·Granted Feb 5, 2019·0 cites·20 claims
- 3040US2009005364A1Azole Derivatives With Antimuscarinic ActivityPERETTO ILARIA·Filed 2005·Application pending·0 cites
- 3138US9932338B2Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2016·Granted Apr 3, 2018·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Andrea Rizzi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →